共 50 条
- [31] The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data JOURNAL OF CROHNS & COLITIS, 2020, 14 (02): : 192 - 204
- [37] Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (07):